Walleye Capital LLC Revance Therapeutics, Inc. Put Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$2.34 - $4.73 $78,156 - $157,982	-33,400 Reduced 85.86%	5,500 $14,000
Q1 2024 May 15, 2024	SELL	$4.65 - $9.31 $7,440 - $14,896	-1,600 Reduced 3.95%	38,900 $191,000
Q4 2023 Feb 14, 2024	BUY	$5.81 - $11.2 $215,551 - $415,520	37,100 Added 1091.18%	40,500 $355,000
Q3 2023 Nov 14, 2023	SELL	$11.47 - $25.07 $12,617 - $27,577	-1,100 Reduced 24.44%	3,400 $38,000
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $93,860 - $142,918	3,800 Added 542.86%	4,500 $113,000
Q1 2023 May 15, 2023	BUY	$18.36 - $35.27 $12,852 - $24,689	700 New	700 $22,000
Q3 2019 Nov 14, 2019	SELL	$10.22 - $14.5 $64,386 - $91,350	-6,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.67 - $15.49 $67,221 - $97,587	6,300 New	6,300 $82,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.